SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001193125-17-248750
Filing Date
2017-08-04
Accepted
2017-08-04 16:11:06
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13D d419906dsc13d.htm SC 13D 35281
  Complete submission text file 0001193125-17-248750.txt   37337
Mailing Address 4400 BISCAYNE BLVD. MIAMI FL 33137
Business Address 4400 BISCAYNE BLVD. MIAMI FL 33137 305-575-4138
Opko Health, Inc. (Filed by) CIK: 0000944809 (see all company filings)

IRS No.: 752402409 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D
SIC: 2834 Pharmaceutical Preparations

Mailing Address 10210 CAMPUS POINT DRIVE, SUITE 150 SAN DIEGO CA 92121
Business Address 10210 CAMPUS POINT DRIVE, SUITE 150 SAN DIEGO CA 92121 (858) 909-0749
Sevion Therapeutics, Inc. (Subject) CIK: 0001035354 (see all company filings)

IRS No.: 841368850 | State of Incorp.: DE | Fiscal Year End: 0630
Type: SC 13D | Act: 34 | File No.: 005-56243 | Film No.: 171008748
SIC: 8731 Services-Commercial Physical & Biological Research